What is MBST®? (Multi Bio Signaling Technology)
Nucleus Magnetic Resonance Therapy (NMRT) – is currently the only therapy available that works at cellular level. The scientific technology it uses communicates directly to the cells.
Non-invasive, risk free therapy of pain associated with arthritis, osteoporosis, general wear and tear or sports/accident injuries.
Treats causes of pain at cellular level to heal and relieve symptoms.
Contraindications for the treatment
- Blood infections.
- Cancer in the area of treatment within the past 5 years.
- Pacemakers, particularly if the areas treated are the neck and shoulders.
None – patients generally have better sleep at night after the treatment.
BST® stimulates the hydrogen protons using radio waves, putting them into a ‘high energy’ state, this energy is then released in the same way as in MRI.
When we have an MRI (Magnetic Resonance Imaging) the energy is reflected out and picked up by sensors for the computer technology to turn this into an understandable image for us to see.
When we have MBST®, the radio wave is carrying the right frequency to be absorbed by the surrounding tissue. The devices work via chip cards and they come into play as these frequencies differ depending on what the tissue is that we are trying to act upon. When this ‘energy’ is absorbed by the tissue, it can then be used to recharge the cell as it is the right resonance. This means that, with repeated treatment, we can get the cell back to the right potential energy and healthily regenerate and turn back the clock on the cell making it “younger”. Having the chip cards reduces human error and ensures it increases the rate of success.
BST® should not be confused with other therapies such as PEMF, Shockwave and Magnetic Bracelets and Mattresses, as these only treat symptoms i.e:
EMF works on the ions as opposed to the hydrogen protons. Hydrogen is much more readily available in the body than ions. MBST® is the only device that can actually act at the cellular level. PEMF devices use a single magnetic field and coil meaning that the magnetic field treatment area is only right up against the wall of the device. With MBST® having 3 different fields, the treatment area is throughout the whole device, with strongest in the middle section. That is why it is designed with the bed, making it more open and comfortable for the patient.
Magnetic bracelets claim to assist healing by increasing the flow of blood. The single static magnetic field in these products is not strong enough.
Shockwave therapy encourages blood flow to the area of pain, an important factor in the healing process, however it does not treat the root cause of the pain.
Background of the MBST® Technology
It has been used to treat people for over 17 years.
Originated in Germany and currently available in 29 countries worldwide including China, Russia and Australia.
Based upon similar principles as MRI, MBST® came about after patients reported reduced pain after having had MRI scan.
Mr Muntermann, Dr Overbeck and the team at MedTec found inspiration from these MRI reports and then developed MBST®.
Cell Regeneration is the UK distributor and also has a MBST® dedicated clinic in Stamford, Lincolnshire. MBST® patients are treated in conjunction with physiotherapy or orthopedic consultation and advice on exercise to help aid recovery and rehab. It is important to have post physiotherapy treatment in order to return muscle memory to its pre-injured state, and also to manage the expectations of the patient in recovery. As MBST® works at cellular level, response time will vary in each individual patient. We ask all patients to give MBST® 10 weeks as a consistent recovery time after the treatment in order to see results. The outcome of treatment can then be checked on a MRI scan after this period.
How does MBST® work
MBST® is made up of a treatment unit that uses three different electro-magnetic fields.
The magnetic fields alternate, reacting with the damaged cells in order to stimulate their regeneration. This results in increased function of the joint, often eliminating the need for surgery.
Patients can be treated whilst relaxing, lying down or in a chair, depending on the area being treated by MBST®.
Who can be treated by MBST®
People who suffer from a degenerative disease in joints and bones and metabolic bone disorders, such as osteoarthritis and osteoporosis. However it should be noted that patients with osteoarthritis in stages 4 or 5 may have a longer cell regeneration healing time.
People with bulging discs, sports injuries, broken bones, cartilage tears, ligament and tendon damage.
Injured athletes, returning them to their sport at a faster and safer rate.
People who suffer from pain and reduced mobility due to degeneration of bone tissue and joints. This is when the signals that should be aiding in the regeneration of bone and cartilage are not working properly.
In veterinary for horses and dogs.
Example of Clinical Studies available:
There are a number of studies into MBST® Magnetic Resonance Therapy and its effects on bone mineral density and osteoblasts:
Handschuh and Melzer:
Looked at 54 patients between January 2004 and March 2006, 41 were assessed 6 months after treatment.
QCT (Quantitative Computed Tomography) on the lumbar spine was used to determine the patients had bone density found in osteopenia (less severe than osteoporosis) or manifest OP (Osteoporosis). This was carried out by a radiology centre. The same centre was used 6 months after the treatment under standardised conditions to review the density.
Patients received treatment on 10 consecutive weekdays for 1 hour at the same time of day using a conventional whole body Magnetic Resonance Therapy couch.
The patients who were receiving long-term treatment of Teriparatide didn’t show any significant increase. Patients who weren’t on long -term treatment of Teriparatide however, did see their bone density increase from 97.5 mg/ml to 100.2 mg/ml after undergoing MBST®.
Studied the long term effects of the therapeutic use of nucleus magnetic resonance (NMRT) on bone mineral density (BMD) parameters in patients with OP.
They took 103 patients aged 45-89 who had T-scores of BMD less than -2.5. These patients received MBST® for one hour per day on 10 consecutive days.
DEXA (dual energy x-ray absorptiometry) were used to measure BMD at baseline and 12 months post treatment.
From baseline to 12 months they saw significant increases of BMD and serum levels of osteocalcin (bone protein). CTX (C-terminal cross-linked telopeptide of type I collagen, aka: Collagen type I X) remained stable.
The team concluded that “NMRT- can be considered a useful alternative or supplement to medical therapy in patients with osteoporosis.”
In 2005, a study was undertaken to see what effect NMRT had on cell proliferation, cellular apoptosis (cell death/change) and the viability of human chondrocyte and osteoblasts.
The study lasted 19 days; 9 days having one hour of treatment per day and then a cell count used after 10 further days.
They used commercially viable human cell lines.
After 10 days NMRT “did not induce apoptosis or inhibit cell viability but revealed a tendency of an elevated cell proliferation rate.”
Cell Regeneration’s clinic treats patients from all over the country and has the distribution rights of MBST® Magnetic Resonance Therapy as a base point sales agent in the United Kingdom.
The intention is to make MBST® widely available within the UK in the next 3 years.